Delivery Order SPE2DB20D1004-SPE2DB23FG5Y3
Award Date
9/19/23
Potential Completion Date
9/20/23
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,129.72 Firm Fixed Price delivery order contract is for the provision of 4566831562 VYVANSE 20 MG CAPSULE 100S, with an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,505.72 firm fixed-price delivery order contract is for the provision of 4564909224 - VYVANSE 40 MG CAPSULE 100S. The contract has an ultimate completion date of June 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,052.30 firm fixed-price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.63 firm fixed-price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,994.76 firm fixed-price delivery order is for the supply of VYVANSE 30 MG CAPSULE 100S, with a period of performance through October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, identified as SPE2DB20D3104|SPE2DB25FV4L4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,997.50 firm fixed-price delivery order is for the supply of 4566845521 VYVANSE 30 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FF8U7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,396.99 firm fixed-price delivery order is for the supply of 4564375487 VYVANSE 10 MG CAPSULE 100S. The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated with any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 21, 2024. The $2,225.85 delivery order contract is for the supply of 4566514913 VYVANSE 50 MG CAPSULE 100S, a medication product. The contract has a firm fixed price and a completion date of November 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,070.56 firm fixed-price delivery order is for the supply of 4553789075 VYVANSE 20 MG CAPSULE 100S, with a completion date of June 8, 2021. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,008.88 firm fixed-price delivery order contract is for the supply of 4567689651 VYVANSE 40 MG CAPSULE 100S, a specialty medication. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...